Van Eck Associates Corp Thermo Fisher Scientific Inc. Transaction History

Van Eck Associates Corp

  • $78.1 Billion
  • Q4 2024

A detailed history of Van Eck Associates Corp transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 418,365 shares of TMO stock, worth $254 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
418,365
Previous 349,438 19.73%
Holding current value
$254 Million
Previous $201 Million 8.04%
% of portfolio
0.28%
Previous 0.25%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$501.29 - $612.85 $34.6 Million - $42.2 Million
68,927 Added 19.73%
418,365 $218 Million
Q3 2024

Oct 29, 2024
BUY
$531.86 - $624.21 $3.04 Million - $3.57 Million
5,721 Added 1.66%
349,438 $201 Million
Q2 2024

Jul 31, 2024
SELL
$541.52 - $599.02 $16.8 Million - $18.6 Million
-31,057 Reduced 8.29%
343,717 $190 Million
Q1 2024

Apr 30, 2024
BUY
$528.82 - $599.43 $11.9 Million - $13.5 Million
22,557 Added 6.4%
374,774 $218 Million
Q4 2023

Feb 05, 2024
BUY
$431.41 - $532.94 $146 Million - $181 Million
339,013 Added 2567.5%
352,217 $187 Million
Q3 2023

Nov 08, 2023
SELL
$498.29 - $574.41 $973,658 - $1.12 Million
-1,954 Reduced 12.89%
13,204 $6.68 Million
Q2 2023

Aug 03, 2023
BUY
$508.46 - $591.13 $503,883 - $585,809
991 Added 7.0%
15,158 $7.91 Million
Q1 2023

May 03, 2023
BUY
$535.0 - $604.82 $820,155 - $927,189
1,533 Added 12.13%
14,167 $8.17 Million
Q4 2022

Feb 08, 2023
SELL
$484.71 - $571.37 $92,094 - $108,560
-190 Reduced 1.48%
12,634 $6.96 Million
Q3 2022

Oct 27, 2022
SELL
$507.19 - $604.49 $168,894 - $201,295
-333 Reduced 2.53%
12,824 $6.5 Million
Q2 2022

Aug 03, 2022
SELL
$500.9 - $612.21 $1.2 Million - $1.46 Million
-2,390 Reduced 15.37%
13,157 $7.15 Million
Q1 2022

May 10, 2022
SELL
$524.0 - $644.92 $770,280 - $948,032
-1,470 Reduced 8.64%
15,547 $9.18 Million
Q4 2021

Jan 26, 2022
SELL
$569.0 - $667.24 $98 Million - $115 Million
-172,193 Reduced 91.01%
17,017 $11.4 Million
Q3 2021

Nov 03, 2021
SELL
$509.53 - $609.78 $2.77 Million - $3.31 Million
-5,431 Reduced 2.79%
189,210 $108 Million
Q2 2021

Aug 10, 2021
BUY
$441.0 - $508.24 $83.6 Million - $96.3 Million
189,478 Added 3669.92%
194,641 $98.2 Million
Q1 2021

May 13, 2021
BUY
$439.85 - $518.83 $88,409 - $104,284
201 Added 4.05%
5,163 $2.36 Million
Q4 2020

Feb 09, 2021
BUY
$435.06 - $527.66 $380,677 - $461,702
875 Added 21.41%
4,962 $2.31 Million
Q3 2020

Nov 12, 2020
SELL
$359.77 - $441.52 $2.22 Million - $2.73 Million
-6,181 Reduced 60.2%
4,087 $1.8 Million
Q2 2020

Aug 10, 2020
SELL
$275.2 - $362.34 $863,852 - $1.14 Million
-3,139 Reduced 23.41%
10,268 $3.72 Million
Q1 2020

May 12, 2020
SELL
$255.3 - $340.05 $746,241 - $993,966
-2,923 Reduced 17.9%
13,407 $3.8 Million
Q4 2019

Feb 13, 2020
SELL
$271.93 - $328.04 $1.16 Million - $1.4 Million
-4,257 Reduced 20.68%
16,330 $5.31 Million
Q3 2019

Nov 08, 2019
BUY
$268.46 - $305.43 $173,425 - $197,307
646 Added 3.24%
20,587 $6 Million
Q2 2019

Aug 07, 2019
BUY
$257.51 - $295.55 $450,384 - $516,916
1,749 Added 9.61%
19,941 $5.86 Million
Q1 2019

May 13, 2019
SELL
$212.17 - $273.72 $994,865 - $1.28 Million
-4,689 Reduced 20.49%
18,192 $4.98 Million
Q4 2018

Feb 12, 2019
BUY
$208.47 - $251.98 $434,034 - $524,622
2,082 Added 10.01%
22,881 $5.12 Million
Q3 2018

Nov 13, 2018
BUY
$205.57 - $244.32 $328,912 - $390,912
1,600 Added 8.33%
20,799 $5.08 Million
Q2 2018

Aug 13, 2018
BUY
$203.14 - $219.53 $3.9 Million - $4.21 Million
19,199 New
19,199 $3.98 Million

Others Institutions Holding TMO

# of Institutions
2,809
Shares Held
331M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $238B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email